By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050



Company News
Teva (TEVA) To Report First Quarter 2015 Financial Results On April 30, 2015 4/17/2015 7:58:04 AM
Ex-Teva (TEVA) CEO Becomes Chief of Start-Up Ovid Therapeutics As Orphan Drugs Come Into Focus 4/16/2015 6:14:08 AM
Teva (TEVA) And Eagle Pharmaceuticals (EGRX) Announce NDA For Bendamustine Rapid Infusion Product Accepted For Filing 4/14/2015 8:04:04 AM
Teva (TEVA) To Present Multiple Sclerosis Data At 67th American Academy of Neurology Annual Meeting In Washington, D.C. 4/13/2015 8:33:10 AM
Teva (TEVA)'s Recent Moves Suggest Restructuring Will Focus on Hypertension, Respiratory & CNS Markets 4/6/2015 6:39:58 AM
Teva (TEVA) And Xenon Pharmaceuticals Inc. Announce Enrollment Of First Patient In A Phase 2b Study Evaluating TV-45070 For Postherpetic Neuralgia (PHN) 4/2/2015 7:08:09 AM
Teva (TEVA) Announces FDA Approval of ProAir RespiClick 4/1/2015 10:23:29 AM
Teva (TEVA) Wins $170 Million Contract To Make Vaccine In Forest 3/31/2015 12:05:59 PM
Teva (TEVA) Expands Hypertension Line With Launch Of Generic Exforge Tablets In The United States 3/31/2015 11:22:15 AM
Teva (TEVA) Shells Out $3.2B to Buy Auspex Pharmaceuticals (ASPX) and Boost CNS Business; All Cash, No Debt 3/30/2015 7:29:09 AM